Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Sugar consumption and cardiometabolic risk. With a focus on the urinary sucrose and fructose biomarkers.

Ramne, Stina LU orcid (2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
Abstract
Introduction: In contrast to the intake of sugar-sweetened beverages (SSBs), the evidence linking added sugar intake to the risk of cardiometabolic disease (primarily referring to cardiovascular disease and type 2 diabetes (T2D)) is contradictory.
Aim: The aim of this thesis is to elucidate the role of added sugar intake in the risk for cardiometabolic diseases. To obtain further understanding of such a potential association, the aims include exploring differences between the intake of added sugar and different added sugar sources, studying an objective biomarker of sugar intake and investigating various pathways through which added sugar intake could possibly affect cardiometabolic risk.
Method: In the Malmö Diet and Cancer... (More)
Introduction: In contrast to the intake of sugar-sweetened beverages (SSBs), the evidence linking added sugar intake to the risk of cardiometabolic disease (primarily referring to cardiovascular disease and type 2 diabetes (T2D)) is contradictory.
Aim: The aim of this thesis is to elucidate the role of added sugar intake in the risk for cardiometabolic diseases. To obtain further understanding of such a potential association, the aims include exploring differences between the intake of added sugar and different added sugar sources, studying an objective biomarker of sugar intake and investigating various pathways through which added sugar intake could possibly affect cardiometabolic risk.
Method: In the Malmö Diet and Cancer study and the Malmö Offspring Study, both cross-sectional and prospective associations of intake of added sugar and sugar-rich foods and beverages were investigated along with various cardiometabolic risk markers, cardiometabolic incidence outcomes, the gut microbiota composition and the plasma proteome. Furthermore, the urinary sucrose and fructose biomarkers were investigated from overnight urine samples in the Malmö Offspring Study and from 24-h urine samples in individuals with prediabetes in the PREVIEW study.
Results: U-shaped associations between added sugar intake and all-cause and cardiovascular mortality, T2D incidence and C-reactive protein have been observed, whereas SSB intake was associated with increased all-cause mortality, a higher Firmicutes:Bacteroidetes ratio and a lower abundance of the genus Lachnobacterium in the gut, as well as a T2D-related plasma proteomic profile. Furthermore, the urinary sucrose and fructose biomarkers in overnight urine samples was found to be a useful complement to self-reported sugar intake, but the 24-h urinary sucrose and fructose biomarkers did not perform optimally in a population with prediabetes.
Conclusion: The intake of SSBs was consistently associated with higher cardiometabolic risk via various measures, whereas the total intake of added sugars showed a U-shaped association with cardiometabolic risk. Future evaluation of these associations can be aided by the use of the urinary sucrose and fructose biomarkers, except in already metabolically impaired individuals, in whom this biomarker may not provide an accurate enough measure of sugar intake. (Less)
Please use this url to cite or link to this publication:
author
supervisor
opponent
  • Professor in Nutritional Epidemiology Lilienthal Heitmann, Berit, University of Copenhagen and the Parker Institute, Bispebjerg and Frederiksberg Hospital, Denmark
organization
publishing date
type
Thesis
publication status
published
subject
keywords
Added sugar, Sugar-sweetened beverages, Cardiometabolic risk, Type 2 diabetes, Cardiovascular disease, Urinary sugar biomarker, Sucrose and fructose excretion, Gut microbiota, Plasma proteome
in
Lund University, Faculty of Medicine Doctoral Dissertation Series
issue
2021:80
pages
131 pages
publisher
Lund University, Faculty of Medicine
defense location
Aulan, CRC, Jan Waldenströms gata 35, Skånes Universitetssjukhus i Malmö. Join by Zoom: https://lu-se.zoom.us/j/65281149600?pwd=aHpOQlpwK1RRNEFyWnJESlhFU29Xdz09 password: 809197
defense date
2021-09-10 13:00:00
ISSN
1652-8220
ISBN
978-91-8021-086-7
project
Sugar consumption and cardiometabolic risk
language
English
LU publication?
yes
id
075abf1a-b358-4e99-9ff4-dd40e3eea98f
date added to LUP
2021-08-09 16:16:26
date last changed
2022-06-27 13:01:40
@phdthesis{075abf1a-b358-4e99-9ff4-dd40e3eea98f,
  abstract     = {{Introduction: In contrast to the intake of sugar-sweetened beverages (SSBs), the evidence linking added sugar intake to the risk of cardiometabolic disease (primarily referring to cardiovascular disease and type 2 diabetes (T2D)) is contradictory. <br/>Aim: The aim of this thesis is to elucidate the role of added sugar intake in the risk for cardiometabolic diseases. To obtain further understanding of such a potential association, the aims include exploring differences between the intake of added sugar and different added sugar sources, studying an objective biomarker of sugar intake and investigating various pathways through which added sugar intake could possibly affect cardiometabolic risk. <br/>Method: In the Malmö Diet and Cancer study and the Malmö Offspring Study, both cross-sectional and prospective associations of intake of added sugar and sugar-rich foods and beverages were investigated along with various cardiometabolic risk markers, cardiometabolic incidence outcomes, the gut microbiota composition and the plasma proteome. Furthermore, the urinary sucrose and fructose biomarkers were investigated from overnight urine samples in the Malmö Offspring Study and from 24-h urine samples in individuals with prediabetes in the PREVIEW study. <br/>Results: U-shaped associations between added sugar intake and all-cause and cardiovascular mortality, T2D incidence and C-reactive protein have been observed, whereas SSB intake was associated with increased all-cause mortality, a higher Firmicutes:Bacteroidetes ratio and a lower abundance of the genus Lachnobacterium in the gut, as well as a T2D-related plasma proteomic profile. Furthermore, the urinary sucrose and fructose biomarkers in overnight urine samples was found to be a useful complement to self-reported sugar intake, but the 24-h urinary sucrose and fructose biomarkers did not perform optimally in a population with prediabetes.<br/>Conclusion: The intake of SSBs was consistently associated with higher cardiometabolic risk via various measures, whereas the total intake of added sugars showed a U-shaped association with cardiometabolic risk. Future evaluation of these associations can be aided by the use of the urinary sucrose and fructose biomarkers, except in already metabolically impaired individuals, in whom this biomarker may not provide an accurate enough measure of sugar intake.}},
  author       = {{Ramne, Stina}},
  isbn         = {{978-91-8021-086-7}},
  issn         = {{1652-8220}},
  keywords     = {{Added sugar; Sugar-sweetened beverages; Cardiometabolic risk; Type 2 diabetes; Cardiovascular disease; Urinary sugar biomarker; Sucrose and fructose excretion; Gut microbiota; Plasma proteome}},
  language     = {{eng}},
  number       = {{2021:80}},
  publisher    = {{Lund University, Faculty of Medicine}},
  school       = {{Lund University}},
  series       = {{Lund University, Faculty of Medicine Doctoral Dissertation Series}},
  title        = {{Sugar consumption and cardiometabolic risk. With a focus on the urinary sucrose and fructose biomarkers.}},
  url          = {{https://lup.lub.lu.se/search/files/101037049/311625_2_G5_Stina_R_kappan_inkl_omslag.pdf}},
  year         = {{2021}},
}